A Randomized Phase 1 Pharmacokinetic Study Comparing the Potential Biosimilar LRG201902 With Liraglutide (Victoza(R)) in Healthy Male Subjects

Mai, G; Fan, LL; Li, MP; Zhang, PW; Gan, CY; Huang, Q; Shentu, JZ

Mai, G; Shentu, JZ (corresponding author), Peoples Hosp Deyang City, Phase Clin Trial Ctr 1, Deyang, Peoples R China.; Shentu, JZ (corresponding author), Zhejiang Univ, Res Ctr Clin Pharm, State Key Lab Diag & Treatment Infect Dis, Affiliated Hosp 1,Sch Med, Hangzhou, Peoples R China.

FRONTIERS IN PHARMACOLOGY, 2021; 11 ():

Abstract

Objective: Pharmacokinetic (PK) similarity between biosimilar candidate LRG201902 and European Union-sourced liraglutide reference product (Victoza(R)......

Full Text Link